Showing 1921-1930 of 8080 results for "".
Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Advocacy and Research
https://practicaldermatology.com/series/the-practical-dermatology-podcast/advocacy-and-research/36479/The latest news and updates, plus Harrison Nguyen, MD, MBA, MPH, FAAD, discusses addressing barriers to maximizing biologics for psoriasis, and Mark Lebwohl, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about some of the latest research he has been involvAre You Sure?
https://practicaldermatology.com/issues/april-2025/are-you-sure/35604/We are to treat patients in 3D, reminding them of the value of touch, of conversation, and of relationships. In the end, that’s what it’s all about.Updates in Cutaneous Lupus
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-cutaneous-lupus/33008/Joseph Merola, MD, a dermatologist, rheumatologist, Chair and professor of dermatology at UT Southwestern Medical Center in Dallas, outlines his talks at Masterclasses in Dermatology talking about emerging therapies in cutaneous lupus.The Latest in Blistering Diseases
https://reachmd.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 2
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-2/32758/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss the differences between psoriasis subtypes, the importance of a specialized therapeutic approach targeting the IL-36 pathway for generalized pustular psoriasis, and the role of neutrophiDr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://reachmd.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.Recap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joSDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.FDA Approves Bimzelx for Hidradenitis Suppurativa
https://practicaldermatology.com/series/dermwire-tv/fda-approves-bimzelx-hidradenitis-suppurativa/29518/In this week's DermwireTV, the FDA approves a new treatment for moderate to severe hidradenitis suppurativa; the FDA agrees to review the resubmission of Dupixent for the treatment of CSU; and the president of Merz Aesthetics, North America, joins us to discuss trends in the aesthetic market.